Cancer Biology Research in Pennsylvania
Cancer Biology Research (93.396) awarded $286 million to recipients in Pennsylvania in 218 grants from fiscal 2021 to 2025, 6.7% of the program's national total. The Trustees of the University of Pennsylvania received the most, $91.1 million.
- Awarded in Pennsylvania$286 million
- Awards218
- Share of the program6.7%
- Rank among states5th of 50
- National total$4.3 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 113 | $47.7 million |
| FY 2022 | 129 | $55.8 million |
| FY 2023 | 127 | $60.2 million |
| FY 2024 | 137 | $61.7 million |
| FY 2025 | 117 | $61.0 million |
Recipients in Pennsylvania
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Trustees of the University of Pennsylvania | Colleges and universities | 62 | $91.1 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Other | 58 | $70.9 million |
| The Wistar Institute of Anatomy and Biology | Nonprofits | 22 | $36.5 million |
| Thomas Jefferson University | Colleges and universities | 17 | $23.0 million |
| The Institute for Cancer Research | Nonprofits | 15 | $18.8 million |
| Pennsylvania State University | Other | 12 | $13.2 million |
| The Children's Hospital of Philadelphia | Nonprofits | 8 | $10.4 million |
| Temple University-of the Commonwealth System of Higher Education | Nonprofits | 6 | $5.7 million |
| Drexel University | Colleges and universities | 3 | $5.3 million |
| Magee-Womens Research Institute and Foundation | Nonprofits | 4 | $5.2 million |
Open opportunities under this program
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
See all 35 on the program page
Questions people ask
How much Cancer Biology Research money goes to Pennsylvania?
$286 million from fiscal 2021 to 2025, across 218 awards. Pennsylvania ranks 5th of 50 states and territories for this program.
Who receives Cancer Biology Research money in Pennsylvania?
The largest recipient is The Trustees of the University of Pennsylvania, with $91.1 million in 62 awards. Next are University of Pittsburgh - of the Commonwealth System of Higher Education and The Wistar Institute of Anatomy and Biology.
Can organizations in Pennsylvania apply now?
Yes, 35 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Biology Research in other states
Other large programs in Pennsylvania
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Federal Transit Formula Grants
- Special Education Grants to States
- Child Care and Development Block Grant